LGALS3 and leukemia: However, the viability of leukemia cells after day five was significantly lower in BCP-ALL cells expanded with Gal3-deficient stroma when compared to control OP9, suggesting that extracellular Gal3 can provide considerable chemoprotection for BCP-ALL cells.